When giving single agent docetaxel for patients with metastatic NSCLC who have progressed on platinum and immunotherapy, do you stop after 6 cycles or do you continue as long as tolerated and disease is stable?   

Answer from: Medical Oncologist at Academic Institution
Medical Oncologist at University of Minnesota Medical School
I agree that continuing treatment until progressio...
Sign in or Register to read more